Caitlin John LLC Buys New Shares in HCA Healthcare, Inc. $HCA

Caitlin John LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,139 shares of the company’s stock, valued at approximately $834,000.

A number of other hedge funds also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. increased its stake in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares during the period. Sunbelt Securities Inc. raised its stake in HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after buying an additional 3,945 shares in the last quarter. Liberty Wealth Management LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $1,905,000. Arrowstreet Capital Limited Partnership lifted its position in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the period. Finally, Sei Investments Co. boosted its position in shares of HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after purchasing an additional 100,764 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Argus cut their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. TD Cowen decreased their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Cantor Fitzgerald reduced their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. JPMorgan Chase & Co. lowered their target price on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research report on Thursday, August 20th. Finally, Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.

Get Our Latest Research Report on HCA

HCA Healthcare Stock Performance

HCA stock opened at $419.19 on Friday. The firm has a market cap of $90.75 billion, a PE ratio of 14.03, a price-to-earnings-growth ratio of 1.48 and a beta of 1.10. The firm has a fifty day moving average price of $400.24 and a 200 day moving average price of $441.63. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the business earned $6.84 earnings per share. HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.